Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 49, Pages 12994-12999
Publisher
Proceedings of the National Academy of Sciences
Online
2017-11-18
DOI
10.1073/pnas.1705165114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
- (2017) Benjamin Weichand et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- Interleukin-22: Immunobiology and Pathology
- (2015) Jarrod A. Dudakov et al. Annual Review of Immunology
- Polarization diversity of human CD4+ stem cell memory T cells
- (2015) Masaru Takeshita et al. CLINICAL IMMUNOLOGY
- IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1α
- (2015) Etienne D. Foucher et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The nucleic acid-sensing inflammasomes
- (2015) Tsan Sam Xiao IMMUNOLOGICAL REVIEWS
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection
- (2015) Pedro P Hernández et al. NATURE IMMUNOLOGY
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Promotion of lung tumor growth by interleukin-17
- (2014) Beibei Xu et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation
- (2014) K. Kim et al. CARCINOGENESIS
- The role of the IL-22/IL-22R1 axis in cancer
- (2014) Chrissie Lim et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
- (2014) Ilona Kryczek et al. IMMUNITY
- B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets
- (2014) Dong-Ming Kuang et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
- (2014) Diletta Di Mitri et al. NATURE
- IL-21 induces IL-22 production in CD4+ T cells
- (2014) Ada Yeste et al. Nature Communications
- Inflammasomes in cancer: a double-edged sword
- (2014) Ryan Kolb et al. Protein & Cell
- Unique versus redundant functions of IL-1α and IL-1β in the tumor microenvironment
- (2014) Elena Voronov Frontiers in Immunology
- Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
- (2013) J. Goc et al. CANCER RESEARCH
- ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non-Small Cell Lung Cancer
- (2013) M. Kabbout et al. CLINICAL CANCER RESEARCH
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
- (2013) Stefanie Kirchberger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells
- (2013) Sebastian Kobold et al. Journal of Thoracic Oncology
- Therapeutic opportunities of the IL-22–IL-22R1 system
- (2013) Robert Sabat et al. NATURE REVIEWS DRUG DISCOVERY
- IL-22 Is Mainly Produced by IFNγ-Secreting Cells but Is Dispensable for Host Protection against Mycobacterium tuberculosis Infection
- (2013) Jochen Behrends et al. PLoS One
- Increased Tc22 and Treg/CD8 Ratio Contribute to Aggressive Growth of Transplant Associated Squamous Cell Carcinoma
- (2013) Shali Zhang et al. PLoS One
- Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator
- (2012) Naresh Kumar et al. ACS Chemical Biology
- Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival
- (2012) Yuan Zhuang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin 22-producing CD4+ T cells in malignant pleural effusion
- (2012) Zhi-Jian Ye et al. CANCER LETTERS
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- IL-1 and TGF- Act Antagonistically in Induction and Differentially in Propagation of Human Proinflammatory Precursor CD4+ T Cells
- (2011) K. Hebel et al. JOURNAL OF IMMUNOLOGY
- IL-1 and IL-1 Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
- (2011) P. Rider et al. JOURNAL OF IMMUNOLOGY
- RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota
- (2011) Shinichiro Sawa et al. NATURE IMMUNOLOGY
- AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch
- (2011) Jacob S Lee et al. NATURE IMMUNOLOGY
- Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22
- (2011) Gregory F Sonnenberg et al. NATURE IMMUNOLOGY
- A novel role for IL-22R1 as a driver of inflammation
- (2010) R. Savan et al. BLOOD
- Biology of interleukin-22
- (2010) Kerstin Wolk et al. Seminars in Immunopathology
- CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) Receptor
- (2010) Bin Zhao et al. TOXICOLOGICAL SCIENCES
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
- (2009) S. Z. Ben-Sasson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts
- (2008) W. Zhang et al. CLINICAL CANCER RESEARCH
- Induction, function and regulation of IL-17-producing T cells
- (2008) Kingston H. G. Mills EUROPEAN JOURNAL OF IMMUNOLOGY
- The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
- (2008) Marc Veldhoen et al. NATURE
- IL-21 and TGF-β are required for differentiation of human TH17 cells
- (2008) Li Yang et al. NATURE
- RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22–producing NKp46+ cells
- (2008) Stephanie L Sanos et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started